Giuseppe Danilo Norata
Overview
Explore the profile of Giuseppe Danilo Norata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
155
Citations
3449
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fu H, Vuononvirta J, Fanti S, Bonacina F, dAmati A, Wang G, et al.
Nat Metab
. 2025 Feb;
PMID: 40000839
No abstract available.
2.
Filoni J, Ferrari A, Jofra T, Putignano A, Da Dalt L, Cesarano S, et al.
Commun Biol
. 2025 Feb;
8(1):295.
PMID: 39988700
No abstract available.
3.
Liberale L, Tual-Chalot S, Sedej S, Ministrini S, Georgiopoulos G, Grunewald M, et al.
Nat Rev Cardiol
. 2025 Feb;
PMID: 39972009
Ageing of the cardiovascular system is associated with frailty and various life-threatening diseases. As global populations grow older, age-related conditions increasingly determine healthspan and lifespan. The circulatory system not only...
4.
Pelucchi S, Da Dalt L, De Cesare G, Stringhi R, DAndrea L, La Greca F, et al.
Pharmacol Res
. 2025 Feb;
213:107652.
PMID: 39952371
PCSK9 promotes the degradation of the low-density lipoprotein receptors and its inhibition by monoclonal antibodies or gene silencing approaches results in the reduction of plasma cholesterol levels coupled to that...
5.
Filoni J, Ferrari A, Jofra T, Putignano A, Da Dalt L, Cesarano S, et al.
Commun Biol
. 2025 Jan;
8(1):99.
PMID: 39838096
Tregs for adoptive therapy are traditionally expanded ex vivo using high doses of IL-2. However, the final Treg product has limited survival once infused in patients, potentially affecting therapeutic effectiveness....
6.
Svecla M, Moregola A, Da Dalt L, Nour J, Baragetti A, Uboldi P, et al.
Cardiovasc Diabetol
. 2024 Nov;
23(1):428.
PMID: 39616371
The asialoglycoprotein receptor 1 (ASGR1), a multivalent carbohydrate-binding receptor that primarily is responsible for recognizing and eliminating circulating glycoproteins with exposed galactose (Gal) or N-acetylgalactosamine (GalNAc) as terminal glycan residues,...
7.
Ahmed O, Shavva V, Tarnawski L, Dai W, Borg F, Olofsson V, et al.
J Intern Med
. 2024 Nov;
297(1):47-59.
PMID: 39560367
Background And Objectives: Statins are used for metabolic dysfunction-associated steatotic liver disease (MASLD) (NAFLD) treatment, but their role in this context is unclear. Genetic variants of patatin-like phospholipase domain containing...
8.
Moregola A, Bonacina F, Vingiani G, Frapolli R, Turrini R, Norata G
Pharmacol Res
. 2024 Oct;
209:107442.
PMID: 39374887
Ofatumumab (OFA) and ocrelizumab (OCRE) are two anti-CD20 monoclonal antibodies approved for the treatment of relapsing forms of multiple sclerosis due to their ability to deplete B lymphocytes. The aim...
9.
Amor M, Diaz M, Bianco V, Svecla M, Schwarz B, Rainer S, et al.
Cardiovasc Diabetol
. 2024 Aug;
23(1):298.
PMID: 39143620
Background: Activation of brown adipose tissue (BAT) has gained attention due to its ability to dissipate energy and counteract cardiometabolic diseases (CMDs). Methods: This study investigated the consequences of cold...
10.
Parolini A, Da Dalt L, Norata G, Baragetti A
Curr Opin Clin Nutr Metab Care
. 2024 Jul;
27(5):434-442.
PMID: 39083430
Purpose Of Review: Contemporary guidelines for the prevention of cardio-metabolic diseases focus on the control of dietary fat intake, because of their adverse metabolic effects. Moreover, fats alter innate immune...